Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Capsules
Patent
1994-05-09
1997-07-01
Webman, Edward J.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Capsules
424461, 424494, 424495, 424497, 514951, 514925, A61K 958, A61K 962, A61K 914, A61K 4732
Patent
active
056436025
ABSTRACT:
An oral pharmaceutical composition is described for targeted slow release in the treatment of inflammatory bowel diseases. Also described are pharmaceutical compositions for peroral treatment targeted to different areas of the intestinal tract afflicted by ulcerative colitis and certain aspects of Crohn's disease.
REFERENCES:
patent: 3983233 (1976-09-01), Brattsand et al.
patent: 3996356 (1976-12-01), Brattsand et al.
patent: 4606940 (1986-08-01), Frank et al.
patent: 4708867 (1987-11-01), Hsiao
patent: 4966770 (1990-10-01), Giannini et al.
Wolman et al., Scand. J. Gastroenterology, vol. 24, Suppl. 15, pp. 146-147 (1989).
Manufacturer's Info. (FMC Corporation) re: "Aquacoat" (ethyl-cellulose), 1987: Altering Drug Release Rates-Coating Methods.
Manufacturer's Info. re: "Eudragit" (Apr. 1989), Lehmann, et al., Practical Course in Lacquer Coating and Survey of Course (Apr. 1989) relating to the use of Eudragit, pp. 1-167.
Johansson et al., Eur. J. Respir. Dis., vol. 63, Suppl. 122, pp. 74-84, 1982.
Manufacturer's Info. re: "Aquacoat" (ethylcellulose), pp. 17-36, 1985.
H. Bechgaard "Critical factors influencing gastrointestinal absorption--what is the role of pellets?" Acta Pharmaceutic Tech 28 (1982) 149.
Wolman "Use of Oral Budesonide in a Patient with Small Bowel Crohn's Diseae . . . " Scand. J. Gastroenterol. 24 (1989) pp. 146-147.
Danielsson et al. "A controlled randomized trial of Budesonide 20. Prednisolone Retention Enemas . . . " Scand. J. Gastroenterol. 22 (1987) pp. 987-992.
Levine et al. "Coating of Oral Beclomethasone Dipropionate Capsules with Cellulose Acetate Phthalate . . . " Gastroenterology 92 (1987) pp. 1037-1044.
Richards et al. "Absorption of Delayed Release A Prednisolone in Ulcrative Colitis and Crohn's Disease", J. Pharm. Pharmacol. 37 (1985), pp. 757-758.
Jewell "Corticosteroids for the Management of Ulcerative Colitis and Crohn's Disease" 18 (1989) pp. 21-34.
Jamstedt et al. "Effect of Bethmethasone Treatment on Iodothyronimes and Thyroid Hormone-binding Proteins During Controlled Nutrition", Acta Endocrinologica 103 (1983) pp. 188-191.
Malchow et al., "Therapie des Morbus Crohn" Deutsche Medizinische Wochenschrift 1090 (1984) pp. 1811-1816.
Andersson et al., "In Vitro Biotransformation of Glucocorticoids in Liver and Skin Homogenate Fraction from Man, Rat and Hairless Mouse". J. Steroid Biochem. 16 (1982) pp. 787-795.
Anders Gamstedt et al 1983 "Effect of betamethasone treatment . . . " Acta Endocrinology 103: 188-191.
A. Kresznai et al. 1986 "Decreased number of steroid receptors . . . " Haematologia 19: 299-301.
P. Thomas et al. 1985 "Absorption of delayed--release . . . " J. Pharmaceutical Pharmocology 37: 757.
Kumana et al. 1982 "Beclomethasone dipropionate enemas . . . " Lancet 1 pp. 579-583 (Dialog).
Astra Aktiebolag
Webman Edward J.
LandOfFree
Oral composition for the treatment of inflammatory bowel disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oral composition for the treatment of inflammatory bowel disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oral composition for the treatment of inflammatory bowel disease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-594971